Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Prazosin MeSH Descriptor Data 2026


MeSH Heading
Prazosin
Tree Number(s)
D03.633.100.786.750
Unique ID
D011224
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D011224
Scope Note
A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
Entry Term(s)
Furazosin
Minipress
Pratsiol
Prazosin HCL
Prazosin Hydrochloride
Pharm Action
Antihypertensive Agents
Adrenergic alpha-1 Receptor Antagonists
Registry Numbers
XM03YJ541D
0
X0Z7454B90
Related Numbers
19216-56-9
19237-84-4
X0Z7454B90
CAS Type 1 Name
Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)-
NLM Classification #
QV 151
Previous Indexing
Piperazines (1974-1976)
Quinazolines (1974-1976)
Public MeSH Note
86; was see under QUINAZOLINES 1977-85
History Note
86(77); was see under QUINAZOLINES 1977-85
Date Introduced
1986/01/01
Last Updated
2017/05/24
Prazosin Preferred
Pratsiol Narrower
Minipress Narrower
Prazosin Hydrochloride Narrower
page delivered in 0.14s